TRV GP VI, LLC
Follow13F filer, CIK 1990716, Boston, MA
TRV GP VI, LLC reported $243,857,193 across 5 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.
Accepted , ingested 13F-HR 0001193125-26-463547
- Period
- 2026-09-30
- Reported value
- $244M
- Holdings
- 5
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Part of the filer group Third Rock Ventures VI, L.P.
TRV GP V, LLCThird Rock Ventures GP IV, L.P.
- TRV GP V, LLC
- Third Rock Ventures GP IV, L.P.
- Third Rock Ventures GP V, L.P.
- Third Rock Ventures GP VI, L.P.
- Third Rock Ventures GP V, LP
- Third Rock Ventures IV, L.P.
- Third Rock Ventures VI, L.P.
- Third Rock Ventures V, L.P.
Stakes and trades reported after 2026-09-30
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- TCXB TCGX ACQUISITION CORP II: 13G 990,000 shares, 9.5% of the class, 13G filed 2026-10-26, 0001193125-26-432002Timeline
Accepted , ingested
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| LSTAnew | +48,446 | $69.8K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001193125-26-463547, largest first. % of portfolio is the value over $243,857,193, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| SEPNSEPTERNA INC | 4,211,659 | $165M | 67.58% | 0 | Timeline | ||
| SPTXSEAPORT THERAPEUTICS INC | 2,061,222 | $41.6M | 17.05% | 0 | Timeline | ||
| RAPPRAPPORT THERAPEUTICS INC | 969,218 | $32.6M | 13.35% | 0 | 2026-10-30, Form 4: granted 238,095 shares on 2026-10-30 | Timeline | |
| TNGXTANGO THERAPEUTICS INC | 194,174 | $4.84M | 1.99% | 0 | Timeline | ||
| LSTALISATA THERAPEUTICS INC | 48,446 | $69.8K | 0.03% | new | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-463547 | base | 2026-11-16 |